BDX Jan 2024 270.000 call
- Zacks
BD's (BDX) Novel Blood Collection System MiniDraw Gets FDA Nod
BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.
- Insider Monkey
Dividend Aristocrats List: Top 25 Among Billionaires
In this article, we will discuss top 25 dividend aristocrats among billionaires. You can skip our detailed analysis of dividend aristocrats and the performance of dividend growers in the past, and go directly to read Dividend Aristocrats List: Top 10 Among Billionaires. Investing in dividend stocks offers a distinct opportunity for investors seeking consistent income. […]
- Reuters
UPDATE 1-US FDA clears Becton's less-invasive blood collection device
Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) cleared its finger-prick blood collection device that could provide a less-invasive option for some commonly ordered lab tests. The device, BD MiniDraw Collection System, can help collect blood samples from a patient's finger through a trained healthcare professional without the need to do it from a vein, the company said. The clearances include blood collection for commonly ordered lab tests such as for lipid panel and tests to diagnose and monitor a variety of chronic conditions from hypertension to high cholesterol, it said.
